Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Berlin
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Allergy Therapeutics PLC

+ Add to Watchlist

HHU:GR

0.253 EUR 0.005 1.94%

As of 03:08:40 ET on 03/27/2015.

Snapshot for Allergy Therapeutics PLC (HHU)

Open: 0.253 Day's Range: 0.253 - 0.253 Volume: 0
Previous Close: 0.258 52wk Range: 0.176 - 0.348 1-Yr Rtn: +2.43%

Stock Chart for HHU

No chart data available.
  • HHU:GR 0.253
  • 1M
  • 1Y
0.258
Interactive HHU Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for HHU

Current P/E Ratio (ttm) -
Estimated P/E(06/2015) 92.6816
Relative P/E vs. DAX -
Earnings Per Share (GBP) (ttm) -
Est. EPS (GBP) (06/2015) 0.0020
Est. PEG Ratio -
Market Cap (M EUR) 103.74
Shares Outstanding (M) 410.06
30 Day Average Volume 0
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 09/22/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for HHU

  • Revenue
  • Net Income (M/GBP)
  • Profit Margin (%)

Company Profile & Key Executives for HHU

Allergy Therapeutics Plc is a specialty pharmaceutical company that develops medical drugs for the treatment and prevention of allergies. The Company sells and distributes vaccine products ranging from general seasonal pollen allergy vaccinations for common allergies to patient-specific short run batches for less common allergens.

Manuel LlobetChief Executive OfficerIan PostlethwaiteFinance Director/Secretary
More Company Profile & Key Executives for HHU

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil